Pricing & Sizes
Ships sealed and lyophilized — stable for years at room temperature, supplied as lyophilised powder. Free shipping on every order, no minimum. Every batch ships with its lab report. Reports come from third-party labs including Janoshik, Freedom Diagnostics and Chromate, most verifiable through the lab's own public portal. Ask and we will send the report for your batch.
Reconstitution — bacteriostatic water: 50mg vial reconstituted at 2mL gives 25mg/mL; 100mg vial reconstituted at 3mL gives 33.3mg/mL. These are concentrations, calculated from vial content and diluent volume. They describe the solution, not a dose.
Email To OrderAlso Available in These Blends
In Plain English
GHK-Cu is a tiny peptide that grabs onto a copper atom and carries it where the body needs it for tissue repair. You make it naturally, and you make steadily less of it as you age — which is the basic reasoning behind adding it back. Copper is essential for building collagen and elastin, the proteins that keep skin firm and wounds closing properly.
What people use it for. Skin quality, fine lines and firmness, hair, and wound or tissue repair. It is the most cosmetically oriented compound in the range and has been used in skincare for decades.
What to know before you buy. The research base here is the strongest of anything we carry, with one important qualifier: most of it studied GHK-Cu applied to the skin, not injected. That does not mean injectable use is worthless, but it does mean the headline research is not quite testing the thing being sold. The blue colour is the copper and is expected. Its FDA review has not happened yet.
What It's Studied For
| Research area | What that rests on |
|---|---|
| Skin elasticity research | Controlled human topical studies reporting improvement in firmness, elasticity, and fine lines |
| Collagen synthesis | Stimulates collagen and glycosaminoglycan synthesis in skin fibroblasts |
| Wound and tissue repair | Accelerated closure and improved tissue quality across animal and human work |
| Hair follicle research | A smaller but genuine body of research |
| Replacing what age takes | Plasma levels fall substantially from early adulthood onward |
The left column lists the research areas this compound is investigated in; the right column states what that rests on. These are published research findings, not proven outcomes or treatment claims, and nothing here is a recommendation. Sold for laboratory research use only.
At a Glance
- Class
- Naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) complexed with copper(II)
- Origin
- Isolated from human plasma by Dr Loren Pickart, 1973
- Age decline
- Plasma levels fall substantially from early adulthood into later life, which underpins much of the interest in supplementation
- Evidence
- The deepest of any compound here — including controlled human topical studies in dermatology
- Regulatory (US)
- Not FDA-approved as a drug. Widely used in cosmetics. Not on the July 2026 PCAC agenda, but named on the published agenda for the February 2027 PCAC meeting
- Next review
- Confirmed. FDA has published the February 2027 PCAC agenda and GHK-Cu is on it, alongside LL-37, Dihexa acetate, Melanotan II and PEG-MGF
- Format
- 50mg and 100mg vials
Regulatory status — separate track
GHK-Cu was not among the seven peptides reviewed at the July 2026 PCAC hearing. Mintz reports that a second PCAC meeting covering an additional five peptides is expected before the end of February 2027, and GHK-Cu is on that later track. Coverage describing peptides as recommended or cleared in July 2026 does not apply here. Its status is unchanged and unresolved.
What the Research Shows
GHK-Cu is the rare compound in this category where the phrase “human data” means controlled studies rather than case series. The dermatological literature is the strongest part:
- Collagen synthesis — stimulation of collagen and glycosaminoglycan production in skin fibroblasts
- Wound healing — accelerated closure and improved tissue quality across animal and human work
- Skin remodelling — controlled topical studies reporting improvements in firmness, elasticity, and fine lines
- Antioxidant and anti-inflammatory activity — documented in multiple models
- Hair follicle support — a smaller but real body of work
Route matters here
The strongest evidence for GHK-Cu is topical. Much of the dermatological literature is built on creams and serums applied to skin, not on injection. That distinction is often blurred in marketing, and it is worth being clear about: injectable use has a thinner evidence base than the headline research suggests.
Practical Notes
GHK-Cu solutions carry a characteristic deep blue colour from the copper complex. This is expected and is not a defect. As with all peptides, visual clarity is a floor for quality assessment rather than a guarantee of potency — a COA is the only meaningful check.
Because copper is an essential but tightly regulated trace mineral, sustained high-dose use is a reasonable thing to raise with a clinician, particularly alongside other copper-containing supplementation.
The bottom line
The best-evidenced compound in this range, with the important qualifier that the strongest data is topical rather than injectable. Its FDA review has not happened yet — expected before the end of February 2027 — so nothing about its compounding status is settled either way.
Also in the Range
Also in GLOW (with BPC-157 and TB-500) and KLOW (adds KPV). The standalone vial is the option if you want the copper peptide without the recovery peptides.